Solomon H. Snyder
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Jacques Glowinski, Neurobiologist and Head of School
Comptes Rendus Biologies Yves Agid Jacques Glowinski, neurobiologist and head of school Volume 343, issue 4 (2020), p. 11-14. Published: 21st April 2021 <https://doi.org/10.5802/crbiol.44> © Académie des sciences, Paris and the authors, 2020. Some rights reserved. This article is licensed under the Creative Commons Attribution 4.0 International License. http://creativecommons.org/licenses/by/4.0/ Les Comptes Rendus. Biologies sont membres du Centre Mersenne pour l’édition scientifique ouverte www.centre-mersenne.org Comptes Rendus Biologies 2020, 343, nO 4, p. 11-14 https://doi.org/10.5802/crbiol.44 Biographical Notes / Notices biographiques Jacques Glowinski, neurobiologist and head of school Jacques Glowinski, neurobiologiste et chef d’école Yves Agida a Institut du Cerveau et de la Moelle, GH Pitié-Salpêtrière, 47 Boulevard de l’Hôpital, 75013, Paris, France E-mail: [email protected] Manuscript received and accepted 16th February 2021. Scientists around the world, and especially mem- There are many great scientists. This was partic- bers of the Academy of Sciences, are reeling from ularly the case when neurobiology was being born the sudden, unexpected disappearance of Jacques in France in the 1970s. We cannot fail to mention Glowinski on November 4, 2020, at the age of 84. For the names of Jean-Pierre Changeux, Jean-Charles those who were close to him and all those who knew Schwartz, Michel Le Moal, and many others, who, at him, it was an immense sadness. the time, were the leaders of the discipline. So why ISSN (electronic) : 1768-3238 https://comptes-rendus.academie-sciences.fr/biologies/ 12 Yves Agid was Jacques Glowinski a scientist out of the ordinary? field. -
Leslie Iversen University of Oxford
OBITUARY - Julius Axelrod Julius Axelrod a Nobel-Prize winning scientist internationally known for his research on brain chemistry and pharmacology died on Wednesday December 29th at his home in Rockville, Maryland near the National Institute of Mental Health, where he worked for most of his career. He was 92. Dr Axelrod shared the 1970 Nobel Prize in Physiology or Medicine with Bernard Katz and Ulf von Euler for fundamental discoveries on neurotransmitters, the chemical messengers used as signals in the nervous system. When such chemicals are released from nerve cells they must be rapidly inactivated and it was widely assumed that this involved their degradation to other inert substances. But Axelrod discovered a completely novel mechanism for the inactivation of neurotransmitters, involving their recapture by the nerves from which they were released. He studied the catecholamine neurotransmitter noradrenaline, present in the peripheral sympathetic nervous system and in the brain. Experiments with radiolabelled noradrenaline showed that when it was injected into experimental animals some was metabolised as expected, but a substantial part of the injected material was taken up and retained unchanged in sympathetic nerves from which it could be released on nerve stimulation. Together with a visiting Austrian scientist, George Hertting, Axelrod in 1961 proposed that the inactivation of noradrenaline involved an uptake system that recaptured much of the neurotransmitter into the same nerves from which it was released. A French visitor, Jacques Glowinski, and Axelrod found that antidepressant drugs acted as powerful inhibitors of this uptake mechanism in brain – and thus acted to prolong the effects of the released neurotransmitter. -
Psychopharmacology Receptors & Inner Pharmacy
JOEL ELKES Where were you born? I was born in Konigsberg which is just across the border from Lithuania. My father was a prominent physician and he was first placed in Konigsberg where he had trained as a medical student. Then the War came and we moved around because my father was an officer in the Russian Army, a physician, a Jew who became very prominent in the Holocaust later. But we moved back and forth in Russia and finally settled in his country of birth, Lithuania, 70 miles from he was born in a little town called Kaunas and became very rapidly a prominent physician in Lithuania. I was educated in Kaunas, which was Kovno in those days. I had my first school training in a school which was totally original. It was a Hebrew school where every subject was taught in Hebrew and that was back in the 1925/26/27, so I read Voltaire and Goethe in Hebrew first. That was done by a band of extraordinary young people who were determined to create a school where one could get a superb general education, which to this day I treasure, in modern Hebrew, the terms being created as we went along. In fact, since we are dwelling on the subject, I remember leaning my trigonometry from stencil sheets which the teachers wrote during the summer, because there were no textbooks and so we had to learn in this way. That was my first education and I finished there in 1930. Then my father sent me to Germany, across the border in Konigsberg. -
Pharmacology and Toxicology of Amphetamine and Related Designer Drugs
Pharmacology and Toxicology of Amphetamine and Related Designer Drugs U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES • Public Health Service • Alcohol Drug Abuse and Mental Health Administration Pharmacology and Toxicology of Amphetamine and Related Designer Drugs Editors: Khursheed Asghar, Ph.D. Division of Preclinical Research National Institute on Drug Abuse Errol De Souza, Ph.D. Addiction Research Center National Institute on Drug Abuse NIDA Research Monograph 94 1989 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute on Drug Abuse 5600 Fishers Lane Rockville, MD 20857 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, DC 20402 Pharmacology and Toxicology of Amphetamine and Related Designer Drugs ACKNOWLEDGMENT This monograph is based upon papers and discussion from a technical review on pharmacology and toxicology of amphetamine and related designer drugs that took place on August 2 through 4, 1988, in Bethesda, MD. The review meeting was sponsored by the Biomedical Branch, Division of Preclinical Research, and the Addiction Research Center, National Institute on Drug Abuse. COPYRIGHT STATUS The National Institute on Drug Abuse has obtained permission from the copyright holders to reproduce certain previously published material as noted in the text. Further reproduction of this copyrighted material is permitted only as part of a reprinting of the entire publication or chapter. For any other use, the copyright holder’s permission is required. All other matieral in this volume except quoted passages from copyrighted sources is in the public domain and may be used or reproduced without permission from the Institute or the authors. -
September 2011
Volume 75 Number 5 September 2011 In this Issue: Lawyers Helping Lawyers Is your family growing? Level Term Life Insurance Individual Own Occupation Disability Insurance IN PERSON, IN YOUR MAILBOX, ONLINE, NIA. NATIONAL INSURANCE AGENCY INC. Professional Association & Affinity Insurance Services WWW.NIAI.COM r PHONE: 502 425-3232 r W R L @ NIAI .COM This issue of the Kentucky Bar CONTENTS Association’s Bench & Bar was published in the month of September. Communications & Lawyers Helping Lawyers Publications Committee Frances E. Catron, Chair, Lexington Paul Alley, Florence 8 Unwell Elizabeth M. Bass, Lexington By Gayle B. McGrath Sandra A. Bolin, Berea Christopher S. Burnside, Louisville James P. Dady, Bellevue 12 Beyond Chemical Dependency: Stress, Depression, Alexander F. Edmondson, Covington Dementia, and the “Addictions without Substance” Judith D. Fischer, Louisville Cathy W. Franck, Crestwood By Dr. Eric Y. Drogin and Dr. Curtis L. Barrett William R. Garmer, Lexington P. Franklin Heaberlin, Prestonsburg Judith B. Hoge, Louisville 16 Chasing Bernadette Z. Leveridge, Jamestown By Yvette Hourigan Christy J. Love, London Theodore T. Myre, Jr., Louisville Eileen M. O’Brien, Lexington 21 Book Review: Point Made: How to Write Like the Richard M. Rawdon, Jr., Georgetown Nation’s Top Advocates Sandra J. Reeves, Corbin E.P. Barlow Ropp, Glasgow By Judith D. Fischer R. Kelley Rosenbaum, Lexington Candace J. Smith, Covington 22 The Law is Still Found in Books Gerald R. Toner, Louisville Sadhna True, Lexington By Taylor Holbrook Katherine Kerns Vesely, Louisville Michele M. Whittington, Frankfort Publisher John D. Meyers Editor Columns Frances E. Catron Managing Editor 3 President’s Page By Maggie Keane Shannon H. -
From the Cover Contents
July 26, 2011 u vol. 108 u no. 30 u 12187–12560 Cover image: Pictured is a Tasmanian devil (Sarcophilus harrisii), a carnivorous marsupial whose numbers are dwindling due to an infectious facial cancer called Devil Facial Tumor Disease. Webb Miller et al. sequenced the genome of devils from northwest and south- east Tasmania, spanning the range of this threatened species on the Australian island. The authors report that the sequences reveal a worrisome dearth of genetic diversity among devils, suggesting the need for genetically characterized stocks to help breed hardier devils that might be better equipped to fight diseases. See the article by Miller et al. on pages 12348–12353. Image courtesy of Stephan C. Schuster. From the Cover 12348 Decoding the Tasmanian devil genome 12283 Illuminating chromosomal architecture 12295 Symmetry of cultured cells 12319 Caloric restriction and infertility 12366 Genetic diversity among ants Contents COMMENTARIES 12189 Methyl fingerprinting of the nucleosome reveals the molecular mechanism of high-mobility group THIS WEEK IN PNAS nucleosomal-2 (HMGN2) association Catherine A. Musselman and Tatiana G. Kutateladze See companion article on page 12283 12187 In This Issue 12191 Examining the establishment of cellular axes using intrinsic chirality LETTERS (ONLINE ONLY) Jason C. McSheene and Rebecca D. Burdine See companion article on page 12295 E341 Difference between restoring and predicting 3D 12193 Secrets of palm oil biosynthesis revealed structures of the loops in G-protein–coupled Toni Voelker receptors by molecular modeling See companion article on page 12527 Gregory V. Nikiforovich, Christina M. Taylor, Garland R. Marshall, and Thomas J. Baranski E342 Reply to Nikiforovich et al.: Restoration of the loop regions of G-protein–coupled receptors Dahlia A. -
REAL-TIME IMAGING of NITRIC OXIDE (NO) SIGNALS DERIVED from DIFFERENTIALLY TARGETED ENDOTHELIAL NITRIC OXIDE SYNTHASES (Enos) USING GENETICALLY ENCODED BIOSENSORS
T.C. BIRUNI UNIVERSITY INSTITUTE OF GRADUATE EDUCATION DEPARTMENT OF MOLECULAR BIOLOGY AND GENETICS MOLECULAR AND MEDICAL GENETICS GRADUATE PROGRAM REAL-TIME IMAGING OF NITRIC OXIDE (NO) SIGNALS DERIVED FROM DIFFERENTIALLY TARGETED ENDOTHELIAL NITRIC OXIDE SYNTHASES (eNOS) USING GENETICALLY ENCODED BIOSENSORS Mete Emir ÖZGÜRSES ADVISOR Asst. Prof. Dr. Emrah EROĞLU July, 2020 T.C. BIRUNI UNIVERSITY INSTITUTE OF GRADUATE EDUCATION DEPARTMENT OF MOLECULAR BIOLOGY AND GENETICS MOLECULAR AND MEDICAL GENETICS GRADUATE PROGRAM REAL-TIME IMAGING OF NITRIC OXIDE (NO) SIGNALS DERIVED FROM DIFFERENTIALLY TARGETED ENDOTHELIAL NITRIC OXIDE SYNTHASES (eNOS) USING GENETICALLY ENCODED BIOSENSORS Mete Emir ÖZGÜRSES ADVISOR Asst. Prof. Dr. Emrah EROĞLU July, 2020 III DECLARATION I declare that I have designed and performed all experiments in the current study entitled “Real-time imaging of nitric oxide (NO) signals derived from differentially targeted endothelial nitric oxide synthases (eNOS) using genetically encoded biosensors” according to good scientific practices. I obtained all the information contained in this thesis under academic and ethical rules. All the information I have used from secondary literature has been respectively referenced. I also declare that have not violated any patents and copyrights during the preparation and writing of this thesis. Mete Emir Ozgurses IV To all human being, V ACKNOWLEDGEMENT I would like to express my deepest gratitude to everyone who has supported me through this thesis. Firstly, I would like to thank Asst. Prof. Emrah Eroğlu for allowing me to work in his lab. He has guided me throughout the project both by challenging me to be more competent in science and by sharing his instructive ideas. -
SCIENCE and SUSTAINABILITY Impacts of Scientific Knowledge and Technology on Human Society and Its Environment
EM AD IA C S A C I A E PONTIFICIAE ACADEMIAE SCIENTIARVM ACTA 24 I N C T I I F A I R T V N Edited by Werner Arber M O P Joachim von Braun Marcelo Sánchez Sorondo SCIENCE and SUSTAINABILITY Impacts of Scientific Knowledge and Technology on Human Society and Its Environment Plenary Session | 25-29 November 2016 Casina Pio IV | Vatican City LIBRERIA EDITRICE VATICANA VATICAN CITY 2020 Science and Sustainability. Impacts of Scientific Knowledge and Technology on Human Society and its Environment Pontificiae Academiae Scientiarvm Acta 24 The Proceedings of the Plenary Session on Science and Sustainability. Impacts of Scientific Knowledge and Technology on Human Society and its Environment 25-29 November 2016 Edited by Werner Arber Joachim von Braun Marcelo Sánchez Sorondo EX AEDIBVS ACADEMICIS IN CIVITATE VATICANA • MMXX The Pontifical Academy of Sciences Casina Pio IV, 00120 Vatican City Tel: +39 0669883195 • Fax: +39 0669885218 Email: [email protected] • Website: www.pas.va The opinions expressed with absolute freedom during the presentation of the papers of this meeting, although published by the Academy, represent only the points of view of the participants and not those of the Academy. ISBN 978-88-7761-113-0 © Copyright 2020 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form, or by any means, electronic, mechanical, recording, pho- tocopying or otherwise without the expressed written permission of the publisher. PONTIFICIA ACADEMIA SCIENTIARVM LIBRERIA EDITRICE VATICANA VATICAN CITY The climate is a common good, belonging to all and meant for all. -
Dr. Salvador Moncada
Sección Gremial Miembro Honorario de la Asociación Hondureña de Neurología, de la Sociedad Hondurena de Epilepsia y de la Federación Centroamericana DR. SALVADOR de Neurología MONCADA El Dr. Salvador Moneada ha de Diciembre de 1944, es, según investigación científica, más de sido electo la revista británica el Scientist, 10 libros científicos, siendo Miembro Honorario de la uno de los 1000 investigadores Doctor en Farmacología y Asociación Hondurena de más citado, de todos los Doctor en Ciencias de la Neurología, de la Sociedad tiempos, por los científicos del Universidad de Londres y Hondurena de Epilepsia y de la mundo, habiendo logrado más teniendo más de 10 doctorados Federación Centroamericana de de 60 premios, incluido el Honoris Causa en Europa, Neurología Premio Príncipe de Asturias Estados Unidos y América Dicho reconocimiento se llevó a 1990 y siendo candidato al Latina. Es el fundador y Direc- cabo durante el Congreso Premio Nobel de Medicina, por tor del Proyecto Cruciforme del Internacional de sus investigaciones, entre las University College London, NEUROCIENCIAS que lleva su cuales están el descubrimiento Londres, Inglaterra. La estatura nombre, realizado en el Hotel del óxido nítrico, de la científica del Dr. Moneada es un Honduras Maya el 18 de agosto tromboxano sintetasa, la fiel ejemplo del legado de de 1997. prostaciclina. nuestros proceres, el Sabio José Cecilio del Valle y Ramón Rosal El Dr. Salvador Moneada nació El Dr. Moneada ha publicado en Tegucigalpa, Honduras, el 3 más de 500 artículos de CURRICULUM VITAE NOMBRE Salvador Moneada LUGAR Y FECHA DE Tegucigalpa, Honduras, 3 de Diciembre, 1944. NACIMIENTO DIRECCIÓN The Cruciform Project, University College London, 140 Tottenham Court Road, London W1P9LN. -
Copyright and Use of This Thesis This Thesis Must Be Used in Accordance with the Provisions of the Copyright Act 1968
COPYRIGHT AND USE OF THIS THESIS This thesis must be used in accordance with the provisions of the Copyright Act 1968. Reproduction of material protected by copyright may be an infringement of copyright and copyright owners may be entitled to take legal action against persons who infringe their copyright. Section 51 (2) of the Copyright Act permits an authorized officer of a university library or archives to provide a copy (by communication or otherwise) of an unpublished thesis kept in the library or archives, to a person who satisfies the authorized officer that he or she requires the reproduction for the purposes of research or study. The Copyright Act grants the creator of a work a number of moral rights, specifically the right of attribution, the right against false attribution and the right of integrity. You may infringe the author’s moral rights if you: - fail to acknowledge the author of this thesis if you quote sections from the work - attribute this thesis to another author - subject this thesis to derogatory treatment which may prejudice the author’s reputation For further information contact the University’s Director of Copyright Services sydney.edu.au/copyright The Trials of Psychedelic Medicine LSD Psychotherapy, Clinical Science, and Pharmaceutical Regulation in the United States, 1949-1976 Matthew Oram A thesis submitted in fulfilment of the requirements for the degree of Doctor of Philosophy Department of History School of Philosophical and Historical Inquiry University of Sydney 2014 ii Declaration of Originality This thesis contains no material that has been accepted for the award of any other degree or diploma in any university or institute of higher learning. -
Importance of the Noradrenaline–Dopamine Coupling in the Locomotor Activating Effects of D-Amphetamine
The Journal of Neuroscience, April 1, 1998, 18(7):2729–2739 Importance of the Noradrenaline–Dopamine Coupling in the Locomotor Activating Effects of D-Amphetamine Laurent Darracq, Ge´ rard Blanc, Jacques Glowinski, and Jean-Pol Tassin Institut National de la Sante´ et de la Recherche Me´ dicale U114, Colle` ge de France, 75231 Paris Cedex 05, France The locomotor hyperactivity induced by systemic or local (nu- DA levels in the nucleus accumbens, and this response was cleus accumbens) D-amphetamine injections can be blocked associated with simultaneous behavioral activation. Both the by systemic or local (prefrontal cortex) injections of prazosin, an increases in extracellular DA levels and in locomotor activity a1-adrenergic antagonist (Blanc et al., 1994). Microdialysis were completely blocked by a pretreatment with prazosin, in- studies performed on freely moving animals indicated that jected either systemically (0.5 mg/kg, i.p.) or locally and bilat- prazosin (0.5 mg/kg, i.p.) does not modify the increase in the erally into the prefrontal cortex (500 pmol/side). Complemen- extracellular dopamine (DA) levels in the nucleus accumbens tary experiments indicated that the focal application of that are induced by D-amphetamine (2.0 mg/kg, i.p.), but it D-amphetamine requires at least a 4.8-fold higher increase in inhibits the D-amphetamine-induced locomotor hyperactivity DA output compared with systemic D-amphetamine for the (263%, p , 0.0001). No behavioral activation occurred after behavioral effects to be elicited. Altogether, these results sug- the bilateral local perfusion of 3 mMD-amphetamine in the gest that locomotor activating effects of D-amphetamine are nucleus accumbens, although it led to a fivefold increase in caused by the stimulation of cortical a1-adrenergic receptors extracellular DA levels. -
Chadi Abdallah, M.D. Associate Member Yale University Ted Abel
Chadi Abdallah, M.D. Ted Abel, Ph.D. James Abelson, M.D., Ph.D Associate Member Fellow Member Emeritus Yale University University of Iowa University of Michigan Elizabeth Abercrombie, Ph.D. Anissa Abi-Dargham, M.D. Megumi Adachi, Ph.D. Fellow Fellow Associate Member Rutgers University Stony Brook University Astellas Research Institute R. Alison Adcock, M.D., Ph.D Nika Adham, B.Sc., M.Sc., Ph.D. Bryon Adinoff, M.D. Associate Member Member Fellow Emeritus Duke University Allergan, Inc. University of Colorado Caleb Adler, M.D. Martin Adler, Ph.D. George Aghajanian, M.D. Member Fellow Emeritus Fellow Emeritus University of Cincinnati Temple University Yale University Bernard Agranoff, B.S., M.D. Susanne Ahmari, M.D., Ph.D Katherine Aitchison, FRCPsy, Prof. Dr. Fellow Emeritus Member med University of Michigan University of Pittsburgh Member University of Alberta Howard Aizenstein, M.D., Ph.D Olusola Ajilore, M.D., Ph.D Schahram Akbarian, M.D., Ph.D Member Member Member University of Pittsburgh University of Illinois at Chicago Icahn School of Medicine At Mount Sinai Huda Akil, Ph.D. Martin Alda, FRCPC, M.D. Robert Alexander, M.D. Fellow Member Member University of Michigan Dalhousie University Takeda George Alexopoulos, M.D. Tanya Alim, M.D. Murray Alpert, Ph.D. Fellow Emeritus Member Fellow Emeritus Weill Cornell Medical College Howard University Larry Alphs, M.D., Ph.D C. Anthony Altar, Ph.D. Susan Amara, Ph.D. Member Member Emeritus Fellow Newron Pharmaceuticals Verge Genomics, Inc National Institute of Mental Health Stephanie Ameis, FRCP(C), M.D., M.Sc. Susan Andersen, Ph.D.